|
Volumn 32, Issue 1, 2018, Pages 161-162
|
Hydroxychloroquine use: The potential impact of new ocular screening guidelines
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HYDROXYCHLOROQUINE;
ANTIRHEUMATIC AGENT;
EYE DISEASE ASSESSMENT;
HUMAN;
LETTER;
MORBIDITY;
OPHTHALMOLOGY;
OPTICAL COHERENCE TOMOGRAPHY;
REMISSION;
RETINAL ASSESSMENT;
RHEUMATOID ARTHRITIS;
PRACTICE GUIDELINE;
RETINA DISEASE;
ANTIRHEUMATIC AGENTS;
HUMANS;
HYDROXYCHLOROQUINE;
PRACTICE GUIDELINES AS TOPIC;
RETINAL DISEASES;
|
EID: 85040362938
PISSN: 0950222X
EISSN: 14765454
Source Type: Journal
DOI: 10.1038/eye.2017.166 Document Type: Letter |
Times cited : (7)
|
References (5)
|